Early Cardiovascular Events in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Although CV events are relatively uncommon in the first 100 days in patients after allogeneic HSCT, the occurrence of CV events is associated with high nonrelapse and all-cause mortality rates. Close monitoring of patients who develop CV events is recommended.
Authors
- Vincent Wang (ORCID: https://orcid.org/0000-0002-3541-2334)
- Tobias Berg (ORCID: https://orcid.org/0000-0003-2668-0449)
- Jane Turner (ORCID: https://orcid.org/0000-0003-1438-217X)
- Jeffrey H. Lipton (ORCID: https://orcid.org/0000-0001-7391-7168)
- MyLinh Duong (ORCID: https://orcid.org/0000-0002-9197-2547)
- Jinhui Ma (ORCID: https://orcid.org/0000-0002-8033-1699)
- Brian F. Leber (ORCID: https://orcid.org/0000-0001-5502-1480)
- Harry Klimis (ORCID: https://orcid.org/0000-0002-3635-421X)
- Anne Holbrook (ORCID: https://orcid.org/0000-0002-3371-4187)
- Irwin Walker (ORCID: https://orcid.org/0000-0003-0430-3837)
- Nazanin Aghel (ORCID: https://orcid.org/0000-0001-7137-9597)
- Dina Khalaf (ORCID: https://orcid.org/0000-0002-2119-6626)
- Christopher Hillis
- Alejandro Garcia‐Horton (ORCID: https://orcid.org/0000-0003-0579-6709)
- Catherine Demers (ORCID: https://orcid.org/0000-0001-5664-345X)
- Philip Joseph (ORCID: https://orcid.org/0000-0002-4844-7093)
- Darryl P. Leong (ORCID: https://orcid.org/0000-0002-1968-169X)
- Jaw‐Jou Kang (ORCID: https://orcid.org/0000-0002-6350-3997)
- Michelle Lui (ORCID: https://orcid.org/0000-0003-1421-9137)
- Kylie Lepic (ORCID: https://orcid.org/0000-0002-7287-0924)
- Luo‐Qin Fu (ORCID: https://orcid.org/0000-0003-3170-9525)
Institutions
- The University of Sydney (AU)
- Juravinski Cancer Centre (CA)
- McMaster University Medical Centre (CA)
- Princess Margaret Cancer Centre (CA)
- Population Health Research Institute (CA)
- Ontario Clinical Oncology Group (CA)
- Impact (CA)
- Hamilton Health Sciences (CA)
- McMaster University (CA)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1016/j.jacadv.2025.101760
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Hamilton Health Sciences